Double Bond Chemical Ind. Co., Ltd.
TWSE:4764.TW
44.3 (TWD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,227.08 | 2,806.07 | 3,063.04 | 2,632.875 | 3,496.96 | 4,530.279 | 4,104.776 | 4,122.703 | 3,587.674 | 3,486.889 | 2,303.692 |
| Cost of Revenue
| 1,994.955 | 2,392.336 | 2,525.197 | 2,189.827 | 2,819.768 | 3,278.141 | 3,142.232 | 3,206.133 | 2,724.036 | 2,690.158 | 1,910.885 |
| Gross Profit
| 232.125 | 413.734 | 537.843 | 443.048 | 677.192 | 1,252.138 | 962.544 | 916.57 | 863.638 | 796.731 | 392.807 |
| Gross Profit Ratio
| 0.104 | 0.147 | 0.176 | 0.168 | 0.194 | 0.276 | 0.234 | 0.222 | 0.241 | 0.228 | 0.171 |
| Reseach & Development Expenses
| 60.505 | 61.763 | 56.615 | 59.342 | 73.497 | 95.736 | 85.041 | 69.292 | 66.142 | 53.851 | 22.638 |
| General & Administrative Expenses
| 123.264 | 125.01 | 126.652 | 118.732 | 132.071 | 142.744 | 143.057 | 132.775 | 176.035 | 154.094 | 96.193 |
| Selling & Marketing Expenses
| 186.139 | 197.144 | 209.932 | 175.842 | 226.416 | 268.412 | 248.939 | 259.942 | 242.214 | 196.856 | 122.887 |
| SG&A
| 285.594 | 322.154 | 336.584 | 294.574 | 358.487 | 411.156 | 391.996 | 392.717 | 418.249 | 350.95 | 219.08 |
| Other Expenses
| 36.165 | 47.79 | 0.476 | 22.622 | 25.586 | 59.467 | 8.601 | 12.4 | 19.265 | 0 | 0 |
| Operating Expenses
| 346.099 | 383.917 | 393.199 | 353.916 | 431.984 | 506.892 | 477.037 | 462.009 | 484.391 | 404.801 | 241.718 |
| Operating Income
| -113.974 | 90.389 | 156.482 | 122.322 | 270.794 | 745.246 | 485.507 | 454.561 | 379.247 | 391.93 | 151.089 |
| Operating Income Ratio
| -0.051 | 0.032 | 0.051 | 0.046 | 0.077 | 0.165 | 0.118 | 0.11 | 0.106 | 0.112 | 0.066 |
| Total Other Income Expenses Net
| 24.976 | -6.383 | -7.102 | -12.338 | -13.677 | 52.159 | 2.59 | 0.661 | 9.379 | 27.957 | 18.278 |
| Income Before Tax
| -88.998 | 84.006 | 149.38 | 109.984 | 257.117 | 797.405 | 488.097 | 455.222 | 388.626 | 419.887 | 169.367 |
| Income Before Tax Ratio
| -0.04 | 0.03 | 0.049 | 0.042 | 0.074 | 0.176 | 0.119 | 0.11 | 0.108 | 0.12 | 0.074 |
| Income Tax Expense
| -3.948 | 23.785 | 42.749 | 47.183 | 59.699 | 232.55 | 156.088 | 137.553 | 128.488 | 106.309 | 33.199 |
| Net Income
| -85.907 | 60.357 | 106.874 | 62.084 | 194.461 | 562.234 | 330.948 | 316.679 | 258.842 | 310.046 | 129.284 |
| Net Income Ratio
| -0.039 | 0.022 | 0.035 | 0.024 | 0.056 | 0.124 | 0.081 | 0.077 | 0.072 | 0.089 | 0.056 |
| EPS
| -1 | 0.71 | 1.25 | 0.72 | 2.23 | 6.46 | 4.18 | 4.09 | 5.42 | 8.2 | 8.81 |
| EPS Diluted
| -1 | 0.71 | 1.25 | 0.71 | 2.08 | 6.21 | 4.18 | 4.07 | 5.39 | 8.16 | 8.75 |
| EBITDA
| 18.471 | 147.744 | 216.887 | 189.667 | 342.343 | 857.32 | 543.593 | 516.386 | 435.005 | 433.696 | 170.684 |
| EBITDA Ratio
| 0.008 | 0.053 | 0.071 | 0.072 | 0.098 | 0.189 | 0.132 | 0.125 | 0.121 | 0.124 | 0.074 |